参考文献/References:
[1]李媛秋,刘剑君,么鸿雁.肺癌发病和死亡流行情况与人类发展指数的关系分析[J].中国肿瘤,2019,28(9):646-650.[2]颜永阳,邓俊,孙宏玉.慢性病患者对“互联网+护理服务”认知和需求研究[J].护理管理杂志,2020,20(11):803-808.[3]徐思璞,乔金平,费广鹤.七项自身抗体在肺癌诊断中的应用[J].安徽医科大学学报,2018,53(6):153-157.[4]Usta E,Bayram S.Determination of factors affecting self transcendence and meaning in life among the elderly receiving institutional care[J].J Relig Health,2021,60(3):2024-2036.[5]赵馨.探讨慢性疾病轨迹护理模式对血友病患儿出血性并发症的影响[J].临床护理杂志,2020,19(2):43-46.[6]雷奕,李妹英,周韶璋,等.以专科护士为主导的口服靶向药物管理方案在肺癌患者延续性护理中的应用[J].广西医学,2020,42(13):1743-1746.[7]魏继贞,项敏.全面护理在贝伐单抗联合培美曲塞治疗肺癌中的应用[J].中国预防医学杂志,2020,21(4):413-416.[8]顾迪.自我调节理论护理方案对NSCLC患者应用安维汀联合化疗治疗依从性的影响[J].国际护理学杂志,2020,39(12):2237-2240.[9]中国健康管理协会.慢性病健康管理规范(T/CHAA 007-2019)[J].中华健康管理学杂志,2020,14(1):12-14.[10]李颖馨,蒋运兰,易银萍,等.慢性病轨迹框架在国外慢性疾病护理中的应用研究[J].护理研究,2019,30(25):3073-3076.[11]高伟.延续护理在非小细胞肺癌患者出院后口服靶向药物治疗中的临床效果研究[J].中国药物与临床,2019,19(9):1583-1584.[12]王建丽,王筱静,孙玉莲,等.吉非替尼联合化疗治疗50例晚期非小细胞肺癌患者的疗效[J].山东大学学报(医学版),2019,57(11):20-26.[13]Hamann HA,Ver Hoeve ES,Carter-Harris L,et al.Mul tilevel Opportunities to Address Lung Cancer Stigma Across the Cancer Control Continuum[J].J Thorac Oncol,2018,13(8):1062-1075.[14]郭洪兵.肺癌手术患者给予强化疼痛护理干预的效果及对SDS、SAS评分的影响[J].吉林医学,2023,44(5):1392-1395.[15]梅彬彬,王濯,沈梅芬,等.基于慢性疾病轨迹模式护理干预对原发性胶质瘤患者生命质量的影响[J].中国实用护理杂志,2017,33(12):895-900.[16]张玲玲,高永平,魏素霞.聚焦解决模式在肺癌手术患者健康教育中的应用[J].河北医科大学学报,2016,37(10):1174-1177.[17]顾宇丹,黄庆峰,金红珍,等.基于慢性疾病轨迹模式干预的原发性脑胶质瘤老年患者负性情绪、生命质量、癌因性疲乏评分变化[J].山东医药,2018,58(11):50-53.[18]张永靖.慢性疾病轨迹模式护理在结直肠癌患者中的应用[J].护理实践与研究,2018,15(9):93-95.[19]黑晓欢,卢丹,陈玥,等.认知性健康教育对肺癌患者生活质量及生存期的影响[J].癌症进展,2019,17(11):1354-1356.[20]王翠,聂立婷,郭敏,等.肺癌患者希望与生活质量的关系——社会支持的中介效应[J].护士进修杂志,2018,33(22):2038-2042.
相似文献/References:
[1]尤 静.肺癌患者外周血CEA、NSE、CYFRA21-1联合检测的意义[J].医学信息,2018,31(06):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
YOU Jing.Clinical Significance of Combined Detection of CEA,NSE,CYFRA21-1 in Peripheral Blood of Patients with Lung Cancer[J].Journal of Medical Information,2018,31(01):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
[2]戴 芳,曹晓美,王莉娜.肺癌患者疾病不确定感的影响因素与干预措施研究现状[J].医学信息,2018,31(08):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
DAI Fang,CAO Xiao-mei,WANG Li-na.Research Status on Influencing Factors and Intervention Measures of Disease Uncertainty in Patients with Lung Cancer[J].Journal of Medical Information,2018,31(01):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
[3]邢益辉,刘 曼,厉玛倩倩,等.快速康复对肺癌手术患者并发症发生及生活质量的影响研究[J].医学信息,2018,31(16):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
XING Yi-hui,LIU Man,LIMA Qian-qian,et al.Effect of Rapid Rehabilitation on Complications and Quality of Life in Patients with Lung Cancer Surgery[J].Journal of Medical Information,2018,31(01):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
[4]朱晓晓,张 顺,蔡 挺.镍暴露相关的肺癌发生分子机制研究[J].医学信息,2018,31(17):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
ZHU Xiao-xiao,ZHANG Shun,CAI Ting.Molecular Mechanism of Lung Cancer Related to Nickel Exposure[J].Journal of Medical Information,2018,31(01):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
[5]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2018,31(01):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[6]覃柳麻,何慧敏.2014~2016年广西肿瘤医院肺癌患者流行病学及病理分布特征分析[J].医学信息,2019,32(05):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
QIN Liu-ma,HE Hui-min.Epidemiological and Pathological Distribution Characteristics of Lung Cancer Patients in Guangxi Cancer Hospital from 2014 to 2016[J].Journal of Medical Information,2019,32(01):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
[7]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Journal of Medical Information,2019,32(01):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[8]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,32(07):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2019,32(01):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
[9]郭 磊,王小文,向小勇.中性粒细胞与淋巴细胞比值与肺癌预后关系研究[J].医学信息,2019,32(09):35.[doi:10.3969/j.issn.1006-1959.2019.09.012]
GUO Lei,WANG Xiao-wen,XIANG Xiao-yong.Relationship between Neutrophil-lymphocyte Ratio and Prognosis of Lung Cancer[J].Journal of Medical Information,2019,32(01):35.[doi:10.3969/j.issn.1006-1959.2019.09.012]
[10]王 猛.循环肿瘤细胞在肺癌诊疗中的临床研究进展[J].医学信息,2019,32(15):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]
WANG Meng.Progress in Clinical Research of Circulating Tumor Cells in the Diagnosis and
Treatment of Lung Cancer[J].Journal of Medical Information,2019,32(01):58.[doi:10.3969/j.issn.1006-1959.2019.15.019]